Limitations and uncertainties of resistance testing: a review of "negative" trials. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
Sherer
R
R
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000235:genetics*; D016903:Drug Monitoring; D024882:Drug Resistance, Viral; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics*; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000295:instrumentation / Q000379:methods* / Q000592:standards; D010641:Phenotype; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D012107:Research Design; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D004279:DNA, Viral